DK0745591T3 - Indanylpyridiner som melatonergiske midler - Google Patents
Indanylpyridiner som melatonergiske midlerInfo
- Publication number
- DK0745591T3 DK0745591T3 DK96401087T DK96401087T DK0745591T3 DK 0745591 T3 DK0745591 T3 DK 0745591T3 DK 96401087 T DK96401087 T DK 96401087T DK 96401087 T DK96401087 T DK 96401087T DK 0745591 T3 DK0745591 T3 DK 0745591T3
- Authority
- DK
- Denmark
- Prior art keywords
- branched
- straight
- indanyl
- hydrogen
- pyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45892195A | 1995-06-02 | 1995-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0745591T3 true DK0745591T3 (da) | 2000-11-20 |
Family
ID=23822638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96401087T DK0745591T3 (da) | 1995-06-02 | 1996-05-17 | Indanylpyridiner som melatonergiske midler |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5703239A (da) |
| EP (1) | EP0745591B1 (da) |
| JP (1) | JPH08333338A (da) |
| AT (1) | ATE194831T1 (da) |
| AU (1) | AU705431B2 (da) |
| CA (1) | CA2176766A1 (da) |
| DE (1) | DE69609379T2 (da) |
| DK (1) | DK0745591T3 (da) |
| ES (1) | ES2150645T3 (da) |
| GR (1) | GR3034645T3 (da) |
| PT (1) | PT745591E (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2753706B1 (fr) * | 1996-09-20 | 1998-10-30 | Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| BRPI0414804A (pt) * | 2003-09-26 | 2006-11-14 | Pfizer Prod Inc | tratamento de perturbações neurológicas relacionadas com perturbações de sono para movimentos oculares rápidos (rem) com antagonistas dos receptores npy y5 |
| MXPA06003380A (es) * | 2003-09-26 | 2006-06-08 | Pfizer Prod Inc | Uso de antagonista del receptor npy y5 para el tratamiento de trastornos del ritmo circadiano. |
| TW200621677A (en) * | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
| US20060122227A1 (en) * | 2004-09-29 | 2006-06-08 | Lior Zelikovitch | Process for alkylating secondary amines and the use in donepezil preparation thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63239220A (ja) * | 1987-03-27 | 1988-10-05 | Taiyo Yakuhin Kogyo Kk | 脳循環代謝改善剤 |
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| FR2635105B1 (fr) * | 1988-08-03 | 1991-01-25 | Synthelabo | Derives de piperazine et leur procede de preparation |
| US5541228A (en) * | 1994-10-14 | 1996-07-30 | Bristol-Myers Squibb Co. | Melatonergic agents |
-
1996
- 1996-04-16 US US08/633,362 patent/US5703239A/en not_active Expired - Fee Related
- 1996-05-16 CA CA002176766A patent/CA2176766A1/en not_active Abandoned
- 1996-05-17 DK DK96401087T patent/DK0745591T3/da active
- 1996-05-17 EP EP96401087A patent/EP0745591B1/en not_active Expired - Lifetime
- 1996-05-17 ES ES96401087T patent/ES2150645T3/es not_active Expired - Lifetime
- 1996-05-17 DE DE69609379T patent/DE69609379T2/de not_active Expired - Fee Related
- 1996-05-17 PT PT96401087T patent/PT745591E/pt unknown
- 1996-05-17 AT AT96401087T patent/ATE194831T1/de not_active IP Right Cessation
- 1996-05-31 AU AU54682/96A patent/AU705431B2/en not_active Ceased
- 1996-06-03 JP JP8139972A patent/JPH08333338A/ja active Pending
-
2000
- 2000-10-19 GR GR20000402331T patent/GR3034645T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2150645T3 (es) | 2000-12-01 |
| US5703239A (en) | 1997-12-30 |
| AU705431B2 (en) | 1999-05-20 |
| EP0745591A1 (en) | 1996-12-04 |
| PT745591E (pt) | 2001-01-31 |
| DE69609379T2 (de) | 2001-03-08 |
| EP0745591B1 (en) | 2000-07-19 |
| AU5468296A (en) | 1996-12-12 |
| ATE194831T1 (de) | 2000-08-15 |
| GR3034645T3 (en) | 2001-01-31 |
| JPH08333338A (ja) | 1996-12-17 |
| CA2176766A1 (en) | 1996-12-03 |
| DE69609379D1 (de) | 2000-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60015927D1 (en) | Phenylharnstoff und phenylthioharnstoffderivate | |
| IL178350A0 (en) | Vitamin d derivatives | |
| NO331068B1 (no) | Benzazepinderivater for behandling av nevrologiske forstyrrelser. | |
| DE60037892D1 (de) | Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis | |
| MXPA04004171A (es) | Inhibidores especificos de fosfodiesterasa tipo 9 para trataiento de trastornos cardiovasculares. | |
| HU9600278D0 (en) | Remedy for nervous diseases | |
| DK1473294T3 (da) | Substituerede1,3-oxathiolaner med antivirale egenskaber | |
| ES2173081T3 (es) | Derivados de benzo- y pirido-pirano que tienen actividad ansilitica y anti-consulsionante. | |
| ATE104145T1 (de) | 4-substituierten imidazolen zur senkung des intraokularen druckes. | |
| DK0745591T3 (da) | Indanylpyridiner som melatonergiske midler | |
| DE60003435D1 (de) | Neue 2-decarboxy-2-phosphinico prostaglandin f analoge | |
| FI914007A0 (fi) | 4-substituerade dihydropyrido (4,3-d) pyrimidiner som smaertslindrande och lokala inflammationshaemmande medel vid vaord av hudsjukdomar. | |
| ATE245643T1 (de) | Substituierte isoxazolylthiophenverbindungen | |
| AP2000002001A0 (en) | Hydroxamic acid derivatives as inhibitors of the production of human CD23 and of the tnf relaease. | |
| DE69911373D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE69527854D1 (de) | Derivate substituierter amidinonaphthylester | |
| DE69902142D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen |